Certara, Inc. (NASDAQ:CERT) Receives Average Recommendation of “Hold” from Analysts

Shares of Certara, Inc. (NASDAQ:CERT) have been assigned an average recommendation of “Hold” from the eight research firms that are covering the firm, MarketBeat.com reports. Six investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $15.92.

CERT has been the topic of a number of research reports. Barclays dropped their price target on Certara from $14.00 to $12.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 7th. UBS Group raised Certara from a “neutral” rating to a “buy” rating and set a $16.00 price objective for the company in a report on Friday, September 27th. Finally, Robert W. Baird decreased their price objective on Certara from $18.00 to $13.00 and set a “neutral” rating for the company in a report on Tuesday, November 5th.

Certara Stock Down 2.0 %

Shares of Certara stock opened at $10.66 on Friday. The company has a current ratio of 2.86, a quick ratio of 2.86 and a debt-to-equity ratio of 0.28. The business’s 50 day simple moving average is $10.84 and its 200-day simple moving average is $12.89. The stock has a market capitalization of $1.72 billion, a price-to-earnings ratio of -53.30, a PEG ratio of 5.70 and a beta of 1.53. Certara has a twelve month low of $9.41 and a twelve month high of $19.87.

Certara (NASDAQ:CERT) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.13 earnings per share for the quarter, topping analysts’ consensus estimates of $0.11 by $0.02. The business had revenue of $94.80 million for the quarter, compared to analysts’ expectations of $95.51 million. Certara had a positive return on equity of 3.43% and a negative net margin of 8.34%. The business’s quarterly revenue was up 10.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.06 EPS. Equities research analysts forecast that Certara will post 0.28 earnings per share for the current year.

Insider Buying and Selling

In other Certara news, insider Patrick F. Smith sold 5,409 shares of the stock in a transaction on Monday, October 7th. The stock was sold at an average price of $11.03, for a total transaction of $59,661.27. Following the completion of the transaction, the insider now directly owns 50,091 shares of the company’s stock, valued at approximately $552,503.73. This trade represents a 9.75 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Leif E. Pedersen sold 51,224 shares of the stock in a transaction on Monday, September 9th. The shares were sold at an average price of $11.29, for a total value of $578,318.96. Following the transaction, the insider now directly owns 99,704 shares of the company’s stock, valued at approximately $1,125,658.16. The trade was a 33.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.39% of the company’s stock.

Institutional Investors Weigh In On Certara

Several large investors have recently modified their holdings of the stock. Wasatch Advisors LP boosted its stake in shares of Certara by 22.4% during the 3rd quarter. Wasatch Advisors LP now owns 9,015,941 shares of the company’s stock worth $105,577,000 after acquiring an additional 1,651,076 shares in the last quarter. Geneva Capital Management LLC boosted its stake in shares of Certara by 0.7% during the 3rd quarter. Geneva Capital Management LLC now owns 5,510,209 shares of the company’s stock worth $64,525,000 after acquiring an additional 37,392 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its stake in shares of Certara by 40.7% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,901,898 shares of the company’s stock worth $45,691,000 after acquiring an additional 1,128,006 shares in the last quarter. State Street Corp boosted its stake in shares of Certara by 3.4% during the 3rd quarter. State Street Corp now owns 3,679,699 shares of the company’s stock worth $43,089,000 after acquiring an additional 122,411 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Certara by 9.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,079,023 shares of the company’s stock worth $42,643,000 after acquiring an additional 273,095 shares in the last quarter. 73.96% of the stock is owned by institutional investors.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.